首页> 外文期刊>Life sciences >Effects of lomefloxacin and norfloxacin on pancreatic beta-cell ATP-sensitive K(+) channels.
【24h】

Effects of lomefloxacin and norfloxacin on pancreatic beta-cell ATP-sensitive K(+) channels.

机译:洛美沙星和诺氟沙星对胰腺β细胞ATP敏感性K(+)通道的影响。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In patients administered lomefloxacin alterations in blood glucose concentrations have been observed in some cases and lomefloxacin has previously been shown to augment insulin release from rat pancreatic islets at micromolar concentrations. The aim of the present study was to compare the effects of two structurally related fluoroquinolones, lomefloxacin and norfloxacin, on ATP-sensitive K(+) (K(ATP)) currents from the clonal insulinoma cell line RINm5F using the whole-cell configuration of the patch-clamp technique. The application of lomefloxacin concentration-dependently blocked K(ATP) currents from RINm5F cells with a half-maximally inhibitory concentration of 81 microM, whereas the application of norfloxacin (at concentrations up to 300 microM) had only minor effects on K(ATP) currents. Block of pancreatic beta-cell K(ATP) currents could be mediated by interaction of lomefloxacin either with the regulatory subunit (SUR1) or with the pore-forming subunit (Kir6.2). We favour the latter hypothesis, since some fluoroquinolones have recently been shown to block the pore-forming subunit of the cardiac rapid delayed rectifier K(+) current I(Kr) (which is encoded by HERG (human ether-a-go-go-related gene)). Thus, as demonstrated for cardiac HERG channels in previous studies and for pancreatic beta-cell K(ATP) channels in the present study, fluoroquinolones differ markedly in their potencies to inhibit K(+) channel activity.
机译:在某些情况下,在接受洛美沙星治疗的患者中观察到血糖浓度发生变化,并且先前已证明洛美沙星以微摩尔浓度增加了大鼠胰岛中胰岛素的释放。本研究的目的是比较两种结构相关的氟喹诺酮类药物洛美沙星和诺氟沙星对使用克隆的胰岛素瘤细胞系RINm5F对ATP敏感的K(+)(K(ATP))电流的影响,使用膜片钳技术。洛美沙星浓度依赖性地阻断RINm5F细胞的K(ATP)电流,其半数抑制浓度最大为81 microM,而诺氟沙星(浓度高达300 microM)的应用对K(ATP)电流仅产生很小的影响。洛美沙星与调节亚基(SUR1)或与成孔亚基(Kir6.2)的相互作用可介导胰腺β细胞K(ATP)电流的阻滞。我们赞成后一种假设,因为最近发现一些氟喹诺酮类药物会阻断心脏快速延迟整流器K(+)电流I(Kr)(由HERG(人为醚相关基因))。因此,如先前研究中对心脏HERG通道和本研究中针对胰岛β细胞K(ATP)通道所证明的,氟喹诺酮类药物在抑制K(+)通道活性方面的功效显着不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号